DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Shimazaki C, Uchida R, Nakano S. et al.
High serum bone-specific alkaline phosphatase level after bortezomib-combined therapy in refractory multiple myeloma: possible role of bortezomib on osteoblast differentiation.
Leukemia 2005; 19 (6): 1102-1103
We do not assume any responsibility for the contents of the web pages of other providers.